STAT+: A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial

May 2, 2023 San Francisco Biotechnology Network News News, Syndication Comments Off on STAT+: A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial
The federal government and Gilead Sciences will square off in a Delaware courtroom this week in a bid to settle dueling claims over patent rights to HIV drugs Truvada and…

Click to view original post

Related Articles

No Picture
News

STAT+: Pharmalittle: FDA increasingly pausing trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug

January 10, 2023 San Francisco Biotechnology Network News News Comments Off on STAT+: Pharmalittle: FDA increasingly pausing trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug

The FDA is pressing pause on testing of experimental medicines more often, a side effect of the drug industry’s move into promising but less-proven technologies. […]